Kevin J. Knopp, President and CEO of 908 Devices Inc. (NASDAQ:MASS), executed a transaction involving the sale of 2,798 shares of the company’s common stock on June 26, 2026. The total value of these sales reached $25,433. The shares were sold at prices ranging from $9.05 to $9.20, resulting in a weighted average price of $9.09 per share.
This sale was executed pursuant to a Rule 10b5-1 trading plan, which Mr. Knopp established on May 20, 2025. Following this transaction, Mr. Knopp directly holds 732,825 shares of 908 Devices common stock. He also indirectly holds an additional 541,223 shares through The Kevin J. Knopp Irrevocable Trust of 2018. While his brother-in-law serves as the trustee with sole voting and dispositive control over the trust’s securities, Mr. Knopp may be deemed the beneficial owner of these shares.
The insider sale comes as 908 Devices shares have shown strong momentum, with the stock posting a 68% return over the past six months. The company currently carries a market cap of $329 million, though it remains unprofitable with earnings per share of -$0.98 over the last twelve months. According to InvestingPro analysis, the stock appears slightly overvalued relative to its Fair Value. For deeper insights into MASS’s valuation and financial health, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities.
In other recent news, 908 Devices Inc. announced its Q1 2026 earnings, highlighting a 14% increase in revenue compared to the previous year, reaching $13.4 million. Despite this growth, the company reported an earnings per share (EPS) of -$0.32, which was below the anticipated -$0.15, resulting in an EPS surprise of -113.33%. This earnings miss did not deter the stock’s pre-market performance, which saw a rise, potentially influenced by strategic initiatives and the positive revenue figures. These developments are part of the company’s recent activities.